2018 ACR/ARHP Annual Meeting

October 19-24, 2018 in Chicago, IL

View by Number View by Title View Sessions

View by Date

Jump to: View All • a [b] c d e f g h i j k l m n o p q r s t u v w x y z

Abstract Number: 2050

B and T Cell Phenotypes of First Degree Relatives of RA Patients in an Indigenous North American Cohort
Abstract Number: 1561

B Lymphocyte Depletion Therapy with Rituximab in Primary Sjögren’s Syndrome: Indications , Effectiveness and Ultrasonographic Response
Abstract Number: 180

Back to Bedside Teaching: Completion of a Rheumatology Rotation Significantly Increases Internal Medicine Residents’ Competency and Comfort with Comprehensive Knee Examinations
Abstract Number: 65

Bacteria-Derived Indole Drives Autoimmune Arthritis By Altering B Cell Glycosylation of Autoantibodies
Abstract Number: 2124

Bacterial Biofilm Product Curli/Edna Induces NETs and Serum Anti-Curli/Edna Levels Correlate with Bacteriuria and Lupus Activity
Abstract Number: 111

BAFF Inhibition Attenuates Fibrosis in Bleomycin-Induced Scleroderma Model Via Modulating the Regulatory and Effector B-Cell Balance
Abstract Number: 1908

Bariatric Surgery Does Not Affect the Incidence of Rheumatoid Arthritis in Obese Subjects
Abstract Number: 1518

Baricitinib and Tofacitinib in Real Life – Does Obesity Impact Response to Janus Kinase Inhibitor Therapy in Rheumatoid Arthritis?
Abstract Number: 970

Baricitinib in Patients with Systemic Lupus Erythematosus: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
Abstract Number: 1894

Baricitinib-Associated Changes in Type l Interferon Gene Signature during a 24-Week Phase-2 Clinical SLE Trial
Abstract Number: 546

Baricitinib: Early Vs. Delayed Start in Patients with Rheumatoid Arthritis
Abstract Number: 1526

Baseline Characteristics and Outcomes in Patients with Anemia in Clinical Studies of Tofacitinib
Abstract Number: 1495

Baseline Characteristics of Methotrexate Inadequate Responder Patients with RA Who Achieved Low Disease Activity with Tofacitinib Monotherapy
Abstract Number: 468

Baseline Features and Outcomes of Pediatric-Onset Discoid Lupus Erythematosus: Interim Data Analysis of a Multicenter Retrospective Cohort Study
Abstract Number: 2588

Baseline Pain Severity As a Predictor of Pain Improvement Following Treatment with Tofacitinib in Psoriatic Arthritis
Abstract Number: 582

Baseline Power Doppler and Multi-Biomarker Disease Activity Score Predict 12-Week Disease Activity Response to Tofacitinib
Abstract Number: 847

Basic Calcium Phosphate Crystals Induce Osteoarthritis-Associated Changes in Chondrocyte Phenotype through Activation of Calcium/Calmodulin Kinase 2
Abstract Number: 280

Be Fierce. Take Control.TM an Evidence-Based Digital Lupus Awareness and Education Campaign for Young Minority Women at Risk for Lupus
Abstract Number: 1802

Behcet’s Disease in the Southwestern United States
Abstract Number: 1975

Behcet’s Disease Lies in the “B” Holder. New Associations in Disease Susceptibility and Manifestations
Abstract Number: 1948

Beliefs and Preferences for Reducing Sedentary Time in Those with Current or Past Knee Symptoms
Abstract Number: 2072

Beneficial Effect of Combination Therapy of Etanercept with Non-Steroidal Anti-Inflammatory Drugs Compared to Etanercept Monotherapy in a Spondyloarthritis Animal Model
Abstract Number: 2537

Benefit Study: Results of Interim Analysis of a Pan-European Observational Study to Evaluate Real-World Effectiveness of SB4 Following Transition from Originator Etanercept (ETN) in Patients with Rheumatoid Arthritis (RA) or Axial Spondyloarthritis (AxSpA)
Abstract Number: 283

Benefits Accrued through the Implementation of Telerheumatology Services
Abstract Number: 2511

Benepali Switches in Clinical Practice – a Positive Single Centre Experience
Abstract Number: 240

Bi-Directional Associations between “Too Much Sitting” and Self-Reported Pain in Patients with Rheumatoid Arthritis
Abstract Number: 1915

Big Data Analysis of Autoimmune Diseases Induced By Cancer Immunotherapies: Identifying Pharmacological Patterns of Organ-Specific Involvement
Abstract Number: 550

Biologic Discontinuation in Rheumatoid Arthritis: A Population Based Study 1999-2017
Abstract Number: 2866

Biologic Refractory Disease in a Cohort Study of Children and Young People with Juvenile Idiopathic Arthritis from the United Kingdom
Abstract Number: 93

Biomarkers Associating Endothelial Function in Systemic Lupus Erythematous
Abstract Number: 957

Biomechanical Therapy for Osteoarthritis of the Knee: A Randomized Controlled Trial
Abstract Number: 2522

Biosimilar BI 695501 and Adalimumab Reference Product (RP) Have Similar Efficacy and Safety in Patients (pts) with Moderately-to-Severely Active Rheumatoid Arthritis (RA): Long-Term Results from a Phase IIIb Extension Study (VOLTAIRE®-RAext)
Abstract Number: 2154

Biosimilar Infliximab Treated-Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis in France: Characteristics and Clinical Outcomes
Abstract Number: 2384

Biosimilar Use in Young Adults with Juvenile Idiopathic Arthritis in Germany
Abstract Number: 2431

Birth Outcomes and Disease Activity during Pregnancy in a Prospective Cohort of Women with Psoriatic Arthritis and Ankylosing Spondylitis
Abstract Number: 2423

Births to Women with Systemic Lupus Erythematosus Can be Identified Accurately in the Electronic Health Record
Abstract Number: 2424

Bisphosphonates during Pregnancy: A Systematic Review Sayanika Kaur MD Fellow Drexel Rheumatology, Mojdeh Khaamesi MD Resident Internal Medicine Arundathi Jayatilleke MD Program Director Drexel Rheumatology
Abstract Number: 2065

Blockade of the JAK/STAT Pathway Inhibits Inflammation and Bone Formation in Two Murine Models of Spondyloarthritis
Abstract Number: 618

Blood Lymphocytes Subtypes As Biomarkers for Early Identification of Optimal Responders to Anti-TNF Treatment in Rheumatoid Arthritis
Abstract Number: 2377

Body Image in Rheumatic Diseases: A Systematic Review
Abstract Number: 2399

Bone Density, Structure and Strength in Canadian Children and Youth with Juvenile Idiopathic Arthritis: The LEAP Study (Linking Exercise, Activity, and Pathophysiology in Canadian Children with Arthritis)
Abstract Number: 1459

Bone Erosion Volume Changes Measured By HR-pQCT at 3-Months after Initiation of Anti-TNF Treatment Predicted Erosion Volume Changes at 1-Year in RA
Abstract Number: 485

Bone Loss in Different Sites over Time in Patients with Rheumatoid Arthritis
Abstract Number: 1597

Bone Mineral Density and Serum Biomarkers of Bone Turnover in Ankylosing Spondylitis Patients Treated with Secukinumab: 2-Year Data from the Pivotal Phase 3 Study
Abstract Number: 956

Bone Mineral Density Is a Causal Risk Factor for Knee and Hip Osteoarthritis: A Population-Based and Mendelian Randomization Study in the UK Biobank
Abstract Number: 2639

Bone Mineral Density Is Not Associated with Osteoporotic Fractures in Premenopausal Women and Men < 50 Years Old with Systemic Lupus Erythematosus
Abstract Number: 2259

BONE Sarcoidosis: A French Case Control Study
Abstract Number: 2701

Botulinum Toxin in the Management of Raynaud’s Phenomenon
Abstract Number: 661

Bridging the Gap between Symptom Onset and Diagnosis in Axial Spondyloarthritis
Abstract Number: 526

Bronchiectasis in RA Is a Crucial Risk Factor of Hospitalised Pneumonia Associated with Bdmards As Well As Interstitial Lung Disease
Abstract Number: 2099

Bruton’s Tyrosine Kinase (BTK) Inhibition Modulates Multiple Cell Types Instrumental in the Pathogenesis of Lupus Nephritis
Abstract Number: 2173

Budget Impact of Etanercept Versus Adalimumab for Treatment of Rheumatoid Arthritis in Biologic-Naïve Patients in the United Kingdom
Abstract Number: 300

Built-in-Electronic-Medical-Record Disease Activity Calculators and Treat-to-Target in Rheumatoid Arthritis
Abstract Number: 1755

Burden of Illness Associated with Eosinophilic Granulomatosis with Polyangiitis (EGPA, formerly Churg-Strauss Syndrome): Evidence from a Managed Care Database in the United States
Abstract Number: 288

Burden of Illness of Treating Patients with Pemphigus vulgaris

Jump to: View All • a [b] c d e f g h i j k l m n o p q r s t u v w x y z